{"id":"CHEMBL100109","canonicalSmiles":"CC(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)B(O)O","inchiKey":"UCQIHCRMWNRFNP-QYZOEREBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL100109","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07658"]},"childChemblIds":["CHEMBL3038261"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200366","canonicalSmiles":"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1.Cl.O","inchiKey":"YHJDZIQOCSDIQU-OEDJVVDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALEXIN HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1727","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Keftab"],"synonyms":["Cefalexin hydrochloride","Cephalexin hcl","Cephalexin hydrochloride","LY-061188","LY061188"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1200497","canonicalSmiles":"CC(O)C(=O)O.CN1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"JOROEVAWQLGPFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLIZINE LACTATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL648","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marezine"],"synonyms":["Cyclizine lactate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200523","canonicalSmiles":"Cc1nnc(SCC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1.[Na+]","inchiKey":"FLKYBGKDCCEQQM-WYUVZMMLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAZOLIN SODIUM","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1435","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ancef","Cefazil","Cefazolin and dextrose","Cefazolin sodium","Cephazolin","Kefzol","Zolicef"],"synonyms":["46083","Cefacidal","Cefamedin","Cefamezin","Cefazil","Cefazolin injection","Cefazolin sodium","Cefazolin sodium salt","Gramaxin","NSC-291561","SK&F 41558","Totacef"],"crossReferences":{"PubChem":["50106031","855770"],"chEBI":["3483"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL1200578","canonicalSmiles":"Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCC(=O)[O-].[Na+]","inchiKey":"AIJQWRAOMFRHTQ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOPHYLLINE SODIUM GLYCINATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1208646","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asbron","Synophylate"],"synonyms":["Bronchoparat","Englate","Glycin theophyllinate","Glytheonate","Panophylline","Theonate sodium","Theophylline sodium glycinate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200881","canonicalSmiles":"CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cl","inchiKey":"GLMUAFMGXXHGLU-VQAITOIOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINOCYCLINE HYDROCHLORIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1434","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acnamino","Aknemin","Aknemin 50","Amzeeq","Arestin","Blemix 100","Blemix 50","Cyclomin","Dentomycin","Dynacin","Minocin","Minocin 50","Minocin mr","Minocycline hydrochloride","Minogal","Minolira","Sebomin","Sebren mr","Solodyn","Ximino","Zilxi"],"synonyms":["Minocycline (as hydrochloride)","Minocycline hcl","Minocycline hydrochloride","NSC-141993"],"crossReferences":{"DailyMed":["minocycline%20hydrochloride"],"PubChem":["144204802","144206734","144211907","170465049"],"chEBI":["50697"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 8 approved and 2 investigational indications."}
{"id":"CHEMBL1200904","canonicalSmiles":"C#CCN(C)[C@H](C)Cc1ccccc1.Cl","inchiKey":"IYETZZCWLLUHIJ-UTONKHPSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELEGILINE HYDROCHLORIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL972","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Centrapryl 10","Centrapryl 5","Eldepryl","Ensam","Selegiline hydrochloride","Stilline 10","Stilline 5","Vivapryl","Zelapar"],"synonyms":["L-deprenyl","NSC-759259","Selegiline hcl","Selegiline hydrochloride"],"crossReferences":{"DailyMed":["selegiline%20hydrochloride"],"PubChem":["144204123","144212163","170464993","26719766","56463000"],"chEBI":["9087"]},"linkedTargets":{"rows":["ENSG00000069535"],"count":1},"linkedDiseases":{"rows":["EFO_0007191","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 2 investigational indications."}
{"id":"CHEMBL1201309","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"PPXLVGBVOZLEIW-ITQXDASVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NAFARELIN","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lhrh, 6(d-nal(2))","Nafarelin"],"crossReferences":{"DailyMed":["nafarelin%20acetate"],"Wikipedia":["Nafarelin"]},"childChemblIds":["CHEMBL1200671"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0001065","EFO_0003843"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for endometriosis and has 3 investigational indications."}
{"id":"CHEMBL1201336","canonicalSmiles":"O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O","inchiKey":"XWLUWCNOOVRFPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSPHENYTOIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fosphenytoin"],"crossReferences":{"DailyMed":["fosphenytoin%20sodium"],"PubChem":["170465016"],"drugbank":["DB01320"],"chEBI":["5165"]},"childChemblIds":["CHEMBL919"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0008526","HP_0002069","EFO_0000474","HP_0001250"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for epilepsy and seizure and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201388","canonicalSmiles":"C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"AAXVEMMRQDVLJB-BULBTXNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDROCORTISONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Astonin-h","Fludrocortisone","NSC-11318"],"crossReferences":{"PubChem":["144206253","144206895","170464959","50125791"],"Wikipedia":["Fludrocortisone"],"drugbank":["DB00687"],"chEBI":["50885"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201542","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP EXTENDED PURIFIED BEEF","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultralente"],"synonyms":["Insulin zinc susp extended purified beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201583","drugType":"Antibody","blackBoxWarning":false,"name":"BEVACIZUMAB","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avastin"],"synonyms":["12-IGG1","AVA-1","Abp-215","BI 695502","BS-503A","Bevacizumab","Bevacizumab beta","Bevacizumab biosimilar (fkb-238)","Bevacizumab-awwb","Bevacizumab-bvzr","Bi-695502","Bs-503","Byvasda","CHS-5217","CT-16","CT-P16","CT-P16 (BIOSIMILAR OF BEVACIZUMAB)","Ct-16","Ct-p16","FKB-238","Fkb238","HLX-04","HLX04","Ibi-305","Ibi305","Mvasi","PF-06439535","Pf-06439535","R-435","RG-435","RHUMAB-","RHUMAB-VEGF","Usp mab 002, monoclonal igg1","Zirabev"],"crossReferences":{"DailyMed":["bevacizumab","bevacizumab-awwb","bevacizumab-bvzr"],"DrugCentral":["4956"],"Wikipedia":["Bevacizumab"]},"linkedTargets":{"rows":["ENSG00000112715"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","EFO_1000231","EFO_0005952","EFO_0009322","EFO_0005773","EFO_1001187","EFO_1001951","EFO_1000880","EFO_0000588","EFO_0000096","MONDO_0002974","EFO_1000251","EFO_0008528","EFO_0002918","Orphanet_2495","EFO_0000760","MONDO_0018271","EFO_1001512","MONDO_0002363","EFO_1000441","MONDO_0002691","EFO_0000630","Orphanet_398934","EFO_1000489","EFO_0000335","EFO_0004284","EFO_0004256","MONDO_0002863","EFO_0001378","EFO_1000796","EFO_0000516","EFO_0009637","EFO_1000412","MONDO_0044903","EFO_0005577","EFO_0001365","MONDO_0002876","HP_0000545","EFO_1001465","EFO_0009606","Orphanet_892","MONDO_0001056","EFO_1001974","EFO_0000196","EFO_0003839","EFO_0002499","EFO_0000183","MONDO_0024677","Orphanet_59305","EFO_1000435","EFO_0007483","EFO_0000403","Orphanet_44890","MONDO_0007576","EFO_0000304","EFO_1001471","EFO_0002517","MONDO_0011962","Orphanet_774","EFO_0000702","MONDO_0024880","EFO_0004264","EFO_0004683","EFO_0001075","MONDO_0045056","EFO_1000657","MONDO_0004222","EFO_0000228","EFO_0000565","EFO_0006462","MONDO_0003268","EFO_0000389","EFO_0003893","EFO_0000698","EFO_0005842","EFO_0006772","EFO_0007143","EFO_0005567","MP_0001845","EFO_1000238","EFO_1000252","EFO_0000233","EFO_1000613","EFO_0000569","EFO_1000172","MONDO_0001280","EFO_1000475","EFO_0002087","MONDO_0021063","EFO_1001469","Orphanet_3437","EFO_1001513","MONDO_0001187","EFO_1000783","EFO_1000044","EFO_0000770","MONDO_0001657","EFO_1000242","EFO_0004212","EFO_0009321","EFO_1001963","EFO_1000042","EFO_1000158","EFO_1000253","Orphanet_523","EFO_0000232","EFO_0004243","EFO_0003060","EFO_0000621","EFO_0000640","EFO_0010282","EFO_0000095","EFO_1000895","EFO_0003050","EFO_0002893","EFO_1000494","EFO_1000233","EFO_1000403","EFO_0011061","EFO_0000365","EFO_0000558","EFO_0000756","EFO_0002917","EFO_1000984","EFO_0000632","EFO_1001952","EFO_0000178","EFO_0000339","EFO_0000564","MONDO_0008903","EFO_0003884","EFO_0000514","EFO_1001111","EFO_0003828","EFO_1000028","EFO_0004288","EFO_1001949","EFO_0000198","EFO_0002618","EFO_1000823","EFO_1001968","MONDO_0008315","EFO_0005221","EFO_0009448","EFO_1000026","EFO_1001231","MONDO_0000544","EFO_0000678","MONDO_0019472","EFO_0000574","EFO_1001158","EFO_0001376","MONDO_0001576","EFO_0000348","EFO_0007416","MONDO_0007254","EFO_0004252","MONDO_0044937","EFO_0009760","MONDO_0002877","MONDO_0002158","EFO_0003968","EFO_0000326","EFO_0000707","HP_0001541","Orphanet_144","EFO_0000616","EFO_0000694","EFO_0006859","EFO_0002916","EFO_1001157","EFO_1001961","MONDO_0021632","MONDO_0002120","MONDO_0017386","MONDO_0002367","MONDO_0018906","EFO_0000519","Orphanet_31837","MONDO_0003060","EFO_0003869","EFO_1000809","EFO_0000571","Orphanet_79383","EFO_0004251","EFO_0000182","EFO_1000101","MONDO_0020634","EFO_0000364","EFO_1000440","EFO_0001416","EFO_0000466","MONDO_0002108","EFO_0000248","MONDO_0008170","EFO_0000349","EFO_0002939","MONDO_0044791","EFO_0009708","EFO_0001061","MONDO_0100096","EFO_1001100","EFO_0005537","EFO_1000358","EFO_0006544","EFO_0008490","EFO_0003016","MONDO_0003005","MONDO_0100342","EFO_0000693","MONDO_0015686","EFO_0001065","EFO_1001901","EFO_1000236","MONDO_0002087","MONDO_0016700","EFO_0000305","EFO_0008626","EFO_0000272","EFO_1000357","EFO_1001480","EFO_1000218","EFO_1000043","EFO_0003860","EFO_0000673","EFO_0002617","EFO_1000037","EFO_1000616","EFO_0000503","EFO_0003770","EFO_0000313","EFO_0002501","EFO_0000311","MONDO_0002989","EFO_0003106","EFO_0009784","EFO_1000581","EFO_0006861","EFO_0002892","EFO_0000174","EFO_0004142","EFO_0003833","EFO_0000691","EFO_0000181","MONDO_0021637"],"count":245},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 18 approved and 175 investigational indications."}
{"id":"CHEMBL1201620","drugType":"Protein","blackBoxWarning":false,"name":"SOMATREM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Protropin"],"synonyms":["Protropin (genentech)","Somatrem"],"crossReferences":{"DrugCentral":["5042"],"Wikipedia":["Somatrem"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1205402","canonicalSmiles":"COc1cc(/C=C\\c2ccc(OC)c(OP(=O)(O)O)c2OP(=O)(O)O)cc(OC)c1OC","inchiKey":"GSOXMQLWUDQTNT-WAYWQWQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXI-4503","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Combretastatin a1 diphosphate","Oxi-4503"],"crossReferences":{"drugbank":["DB05143"]},"childChemblIds":["CHEMBL94021","CHEMBL1812039"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1207444","canonicalSmiles":"CO[C@H]1CC[C@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](O)[C@H]5OC)O4)O3)O2)O[C@@H]1C","inchiKey":"WINSLRIENGBHSH-ASZYJFLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEMDURAMICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Semduramicin","UK-61,689","UK-61689"],"crossReferences":{"drugbank":["DB11545"]},"childChemblIds":["CHEMBL406100"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1214186","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](C[C@@H](N)CC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O","inchiKey":"LMXOHSDXUQEUSF-YECHIGJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SINEFUNGIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COMPOUND 57926","LILLY 57926","LY-57926","Sinefungin"],"crossReferences":{"drugbank":["DB01910"],"chEBI":["45453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230004","canonicalSmiles":"CC(C)NC[C@@H](O)COc1ccc(CC(N)=O)cc1","inchiKey":"METKIMKYRPQLGS-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R(+)-Atenolol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R(+)-Atenolol"],"crossReferences":{"PubChem":["144204762","170464744","50105885","56322620"],"drugbank":["DB06987"],"chEBI":["55352"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230762","canonicalSmiles":"CC(=O)CC(=O)O","inchiKey":"WDJHALXBUFZDSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Acetoacetic_acid"],"drugbank":["DB01762"],"chEBI":["15344"]},"childChemblIds":["CHEMBL3891157","CHEMBL3707335"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230912","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(=O)N[C@H](C=O)CCCNC(=N)N","inchiKey":"SDNYTAYICBFYFH-TUFLPTIASA-N","drugType":"Protein","blackBoxWarning":false,"name":"ANTIPAIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antipain"],"crossReferences":{"drugbank":["DB15251"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233327","canonicalSmiles":"Cn1cnc(C[C@H](N)C(=O)O)c1","inchiKey":"BRMWTNUJHUMWMS-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233327","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04151"],"chEBI":["50599"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235533","canonicalSmiles":"Cc1ncc(C)c(N)n1","inchiKey":"UXKNAXNFIYFMIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235533","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02372"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235676","canonicalSmiles":"CC1=C(N2CC2)C(=O)C(CO)=C(N2CC2)C1=O","inchiKey":"JKDLOGLNPDVUCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235676","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["525640","92763376"],"drugbank":["DB04090"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1271162","canonicalSmiles":"CN1CCC(N2CCN(C(=O)[C@H](NC(=O)c3ccc4cc[nH]c4c3)c3ccccc3)CC2)CC1","inchiKey":"VYNKVNDKAOGAAQ-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-517717","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-517717"],"crossReferences":{"drugbank":["DB05713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1411979","canonicalSmiles":"CN(C)CCN(Cc1cccs1)c1ccccn1","inchiKey":"HNJJXZKZRAWDPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAPYRILENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"],"classes":["Carcinogenicity"],"year":1979},"tradeNames":[],"synonyms":["A 3322","A-3322","Metapyrilene","Methapyrilene","Pyrinistol","Restryl","Semikon","Sleepwell","Tenalin","Thionylan"],"crossReferences":{"PubChem":["11111497","11111498","90341056"],"TG-GATEs":["25"],"drugbank":["DB04819"],"chEBI":["6820"]},"childChemblIds":["CHEMBL1255739","CHEMBL3187246"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergic disease. It was withdrawn in United Kingdom,  United States and  Germany initially in 1979 due to Carcinogenicity."}
{"id":"CHEMBL1428","canonicalSmiles":"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1","inchiKey":"UIAGMCDKSXEBJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NIMODIPINE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nimodipine","Nimotop","Nymalize"],"synonyms":["Admon","BAY E 9736","BAY-E-9736","NSC-758476","Nemotan","Nimodipine","Nimodipine ap","Periplum"],"crossReferences":{"DailyMed":["nimodipine"],"PubChem":["104171194","124880812","124880816","144203753","170466561","26747118","26747119","26747120","26751792","26751793","50104485","50104486","50104487","85231145","90340912"],"Wikipedia":["Nimodipine"],"drugbank":["DB00393"],"chEBI":["7575"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067","ENSG00000151623"],"count":5},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000713","MONDO_0002050","EFO_0002610","EFO_0000545","EFO_0003870","EFO_0000693","HP_0000726","EFO_0000712","EFO_0009846","MONDO_0002679","EFO_0000319","EFO_0003763"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for cardiovascular disease and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1513348","canonicalSmiles":"CCNC(=O)[C@@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@H]1O","inchiKey":"JADDQZYHOWSFJD-BMYQGPEFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1513348","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11114181"],"drugbank":["DB03719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL152408","canonicalSmiles":"CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1","inchiKey":"NZLVRVYNQYGMAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMETHIXENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BP 400","BP-400","Calmixene","NSC-757828","Pimethixene","Pimetixene"],"crossReferences":{"PubChem":["11112606"],"Wikipedia":["Pimethixene"],"drugbank":["DB13292"]},"childChemblIds":["CHEMBL1523827"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1535","canonicalSmiles":"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12","inchiKey":"XXSMGPRMXLTPCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYCHLOROQUINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydroxychloroquine","Polirreumin"],"crossReferences":{"DailyMed":["hydroxychloroquine%20sulfate"],"PubChem":["29215442"],"Wikipedia":["Hydroxychloroquine"],"drugbank":["DB01611"],"chEBI":["5801"]},"childChemblIds":["CHEMBL1690"],"linkedTargets":{"rows":["ENSG00000196664","ENSG00000239732"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000637","EFO_1000710","MONDO_0100130","EFO_0000756","EFO_0000681","EFO_0000228","EFO_1001951","EFO_0000565","EFO_0007160","EFO_0007448","EFO_0000544","EFO_0002690","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0004616","EFO_0004244","EFO_0007541","EFO_0000198","EFO_0002618","EFO_0009686","MONDO_0013730","EFO_0002689","Orphanet_101330","MONDO_0008170","EFO_1001466","EFO_0000349","EFO_0004194","EFO_0000384","MONDO_0008315","EFO_0005221","EFO_0001663","HP_0001873","Orphanet_791","EFO_1001209","EFO_0003840","MONDO_0100096","EFO_0004192","EFO_0007328","EFO_0001378","EFO_0000668","EFO_0000699","MONDO_0100342","DOID_13406","MONDO_0007254","Orphanet_586","EFO_0009001","Orphanet_538","EFO_1000637","Orphanet_912","EFO_0002950","EFO_1000044","EFO_1000218","EFO_0008510","EFO_0007224","EFO_0003047","EFO_1000726","Orphanet_88917","EFO_1000158","EFO_0000694","EFO_0000616","EFO_0000685","EFO_0001645","EFO_0003898","EFO_0000222","EFO_0003818","EFO_0001073","EFO_0003060","EFO_0005755","EFO_0000311","EFO_1000954","EFO_0003106","EFO_0003834","EFO_0004220","EFO_0001068","EFO_0000095","EFO_1001121","EFO_0002614","MONDO_0005147","EFO_0000764","EFO_0000702","EFO_0004142","MONDO_0005148","MONDO_0005178","EFO_0000519","EFO_0000691","MONDO_0021637"],"count":88},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for rheumatoid arthritis and malaria and has 74 investigational indications."}
{"id":"CHEMBL1667969","canonicalSmiles":"O=c1[nH]ccc2cc(OC3CCNCC3)ccc12","inchiKey":"IPEXHQGMTHOKQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-407899","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-407899"],"childChemblIds":["CHEMBL3545341"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["EFO_0001645","EFO_0003884","EFO_0004234"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL169901","canonicalSmiles":"N=C(N)N1CCc2ccccc2C1","inchiKey":"JWPGJSVJDAJRLW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEBRISOQUIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Debrisoquine"],"crossReferences":{"PubChem":["11112418"],"Wikipedia":["Debrisoquine"],"drugbank":["DB04840"],"chEBI":["34665"]},"childChemblIds":["CHEMBL3527581","CHEMBL1593558","CHEMBL1255735"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for hypertension."}
{"id":"CHEMBL17289","canonicalSmiles":"N#CN/C(=N\\CCCCCCOc1ccc(Cl)cc1)Nc1ccncc1","inchiKey":"BOIPLTNGIAPDBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHS-828","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHS 828","Chs 828","Chs-828","GMX 1778","GMX-1778"],"crossReferences":{"PubChem":["174007105"],"drugbank":["DB12980"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1742982","drugType":"Protein","blackBoxWarning":false,"name":"AFLIBERCEPT","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eylea","Zaltrap"],"synonyms":["ABP-938","AVE-0005","AVE0005","Aflibercept","Aflibercept (genetical recombination)","Aflibercept beta","Aflibercept biosimilar (amgen)","Aflibercept recombinant","BAY-86-5321","BAY-865321","BAY86-5321","VEGF TRAP","Vegf trap-eye","Ziv-aflibercept"],"crossReferences":{"DailyMed":["aflibercept","ziv-aflibercept"],"DrugCentral":["4916"]},"linkedTargets":{"rows":["ENSG00000119630","ENSG00000112715"],"count":2},"linkedDiseases":{"rows":["EFO_1001060","EFO_0004683","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0009322","EFO_1001951","EFO_0000565","EFO_1000880","MONDO_0003268","EFO_0000389","EFO_0000501","EFO_0000641","EFO_0003893","MONDO_0008170","EFO_1001466","EFO_1001512","EFO_0005842","MONDO_0004986","EFO_0000574","EFO_0001378","EFO_0000516","EFO_1001158","MONDO_0001576","MONDO_0003005","EFO_0007310","EFO_0001365","MONDO_0004192","MONDO_0021117","EFO_1001465","MONDO_0007254","EFO_0005753","MONDO_0021063","EFO_0008626","EFO_0009760","MONDO_0020654","MONDO_0001187","EFO_0009606","EFO_1001480","EFO_0003860","EFO_0003839","EFO_0002499","EFO_0009321","EFO_0002617","EFO_0000616","EFO_1000616","EFO_0004207","EFO_0000478","EFO_1001157","EFO_0003770","EFO_0002501","EFO_0004243","EFO_0003060","EFO_0000311","EFO_0009784","Orphanet_758","EFO_0000702","EFO_0004142"],"count":60},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 12 approved and 36 investigational indications."}
{"id":"CHEMBL1743006","drugType":"Antibody","blackBoxWarning":false,"name":"DALOTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dalotuzumab","MK 0646","MK-0646","MK0646"],"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_1000044","EFO_1001480","EFO_1001901","MONDO_0008903","MONDO_0007254","EFO_1000657","EFO_0001378","EFO_0003060","EFO_1001951"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL177275","canonicalSmiles":"CCc1c(C)[nH]c(=O)c(N(C)CCOC)c1Cc1cccc(C)c1","inchiKey":"USWKTQVAABDFSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL177275","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07018"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL182066","canonicalSmiles":"O=C(Nc1ccc2[nH]c(=O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1","inchiKey":"GKGRZLGAQZPEHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADIPRODIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RGH-896","Radiprodil","Rgh-896"],"crossReferences":{"drugbank":["DB12260"]},"childChemblIds":["CHEMBL1802037"],"linkedTargets":{"rows":["ENSG00000273079","ENSG00000176884"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","Orphanet_3451"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1871418","canonicalSmiles":"COP(=S)(OC)Oc1cc(Cl)c(Cl)cc1Cl","inchiKey":"JHJOOSLFWRRSGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONNEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Blitex","Dermafos","ENT 23,284","ENT-23284","Ectoral","Etrolene","Fenchlorphos","Fenclofos","Fenclorfos","Fenclorvur","Gesektin k","Korlan","Korlane","NSC-8926","Nanchor","Nankor","OMS-123","Remelt","Ronnel","Rovan","Trichlormetaphos","Trichlorometaphos","Trolen","Trolene","Viozene"],"crossReferences":{"PubChem":["124892624","144206966","144206975","144211651","170466415","26757298"],"drugbank":["DB11456"],"chEBI":["82125"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1897362","canonicalSmiles":"Cc1c(Cl)c(=O)oc2cc(OP(=O)(OCCCl)OCCCl)ccc12","inchiKey":"KULDXINYXFTXMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOXON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Haloxon"],"crossReferences":{"PubChem":["144205442","170466328","29216230"],"drugbank":["DB11419"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL205437","canonicalSmiles":"CN(C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1)C1CCNCC1","inchiKey":"NKLVBHMAIMEVEH-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL205437","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL207433","canonicalSmiles":"O=C(Nc1ccccc1Br)N[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C1","inchiKey":"JYILLRHXRVTRSH-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-705498","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK705498","SB-705498","Sb-705498"],"crossReferences":{"drugbank":["DB11883"]},"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0008521","EFO_0000555","EFO_0010072","EFO_0000274"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL209073","canonicalSmiles":"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12","inchiKey":"RSIHSRDYCUFFLA-DYKIIFRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL209073","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01541"],"chEBI":["34584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103774","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C","inchiKey":"WZDGZWOAQTVYBX-XOINTXKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIBOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Livial"],"synonyms":["NSC-759898","ORG OD 14","ORG-OD 14","Tibolone"],"crossReferences":{"PubChem":["144205803","170465874"],"drugbank":["DB09070"],"chEBI":["32223"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2103857","canonicalSmiles":"COc1ccc(F)cc1C[C@@](O)(C1CCOCC1)[C@@H]1CNCCO1","inchiKey":"CPBHSHYQQLFAPW-ZWKOTPCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDIVOXETINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edivoxetine","LY-2216684","LY-2216684 HYDROCHLORIDE","LY2216684"],"crossReferences":{"drugbank":["DB09184"]},"childChemblIds":["CHEMBL2105702"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0002009"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103869","canonicalSmiles":"O=C(O)[C@@H]1C[C@H]2C[C@@H](Oc3cccc(Cl)c3-c3nnn[nH]3)CC[C@H]2CN1","inchiKey":"LAKQPSQCICNZII-NOHGZBONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASOLAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dasolampanel","NGX426"],"childChemblIds":["CHEMBL3088054"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2103884","canonicalSmiles":"COC[C@H](NC(=O)c1cnc(C)s1)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1","inchiKey":"SWZXEVABPLUDIO-WSZYKNRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPROZOMIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONX 0912","ONX-0912","Oprozomib","Pr-047"],"crossReferences":{"drugbank":["DB11991"]},"linkedTargets":{"rows":["ENSG00000136930","ENSG00000100804","ENSG00000100902","ENSG00000159352","ENSG00000130706","ENSG00000099341","ENSG00000108344","ENSG00000185627","ENSG00000277791","ENSG00000173692","ENSG00000041357","ENSG00000100519","ENSG00000222028","ENSG00000204264","ENSG00000126067","ENSG00000101182","ENSG00000013275","ENSG00000163636","ENSG00000129084","ENSG00000165916","ENSG00000087191","ENSG00000159377","ENSG00000108671","ENSG00000106588","ENSG00000100764","ENSG00000103035","ENSG00000154611","ENSG00000127922","ENSG00000240065","ENSG00000100567","ENSG00000161057","ENSG00000115233","ENSG00000143106","ENSG00000175166","ENSG00000197170","ENSG00000205220","ENSG00000008018","ENSG00000142507"],"count":38},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000616","EFO_0000182","EFO_0001378","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2104824","canonicalSmiles":"c1cc2c(c(NC3=NCCN3)c1)CCC2","inchiKey":"KUCWWEPJRBANHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDANAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indanazoline"],"crossReferences":{"drugbank":["DB13827"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105720","canonicalSmiles":"O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12","inchiKey":"FGQFOYHRJSUHMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LESINURAD","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zurampic"],"synonyms":["Lesinurad","RDEA 594","RDEA-594","RDEA594"],"crossReferences":{"drugbank":["DB11560"]},"childChemblIds":["CHEMBL2105716"],"linkedTargets":{"rows":["ENSG00000197891"],"count":1},"linkedDiseases":{"rows":["EFO_0009104","EFO_0004274"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for gout and hyperuricemia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106468","canonicalSmiles":"CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1","inchiKey":"NLRFFZRHTICQBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICETAMIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-548","Tricetamide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108102","drugType":"Unknown","blackBoxWarning":false,"name":"ST. JOHN'S WORT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chase-devil whole","Common st johnswort whole","Common st. john's wort herb","Common st. john's wort whole","Common st. johnswort whole","Eola-weed whole","Goat-weed whole","Guanyejinsitao","Hyperici herba","Hyperici perforati herba","Hypericum","Hypericum perforatum","Hypericum perforatum extract","Hypericum perforatum l.","Klamath weed flowering top","Klamath weed whole","Klamath-weed whole","Klamathweed flowering top","Klamathweed whole","Powdered st. john's wort extract","Rosin-rose whole","Saint johns wort","St john's wort","St. john's wort","St. john's wort whole","St. john's-wort whole","St. johns wort","St. johnswort flowering top","St. johnswort whole","Tipton's weed whole","Tipton's-weed whole","ZE-117"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2108470","drugType":"Unknown","blackBoxWarning":false,"name":"MURELETECAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mag-camptothecin","Mag-cpt","Mureletecan","PNU-166148"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109060","drugType":"Unknown","blackBoxWarning":false,"name":"LICORICE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B2048","FEMA NO. 2628","FEMA NO. 2629","FEMA NO. 2630","Glycyrrhiza glabra extract","Glycyrrhiza glabra rhizome","Glycyrrhiza glabra root","Glycyrrhiza glabra root powder","Glycyrrhiza glabra root with rhizome","Licorice","NDI 329"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109388","drugType":"Antibody","blackBoxWarning":false,"name":"FUTUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["992 DS","992-DS","Futuximab","SYM-004","Sym004"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","MONDO_0100342","EFO_0000707","EFO_0003060"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2110725","canonicalSmiles":"CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32","inchiKey":"NMDYYWFGPIMTKO-KLCPSUAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINFLUNINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vinflunine"],"crossReferences":{"drugbank":["DB11641"],"chEBI":["90241"]},"childChemblIds":["CHEMBL2105629"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000601","MONDO_0007254","MONDO_0004986","MONDO_0008315","EFO_0003060","MONDO_0001187","EFO_0000311","EFO_0003863","MONDO_0001056","MONDO_0008903","EFO_0000702","EFO_0008528","EFO_0006544","EFO_1001094","MONDO_0002038"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and cancer and has 13 investigational indications."}
{"id":"CHEMBL2111109","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](C(C)C)N(C)C)C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C)C(C)C","inchiKey":"QMCOCIWNMHBIIA-LROMGURASA-N","drugType":"Protein","blackBoxWarning":false,"name":"TASIDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tasidotin"],"childChemblIds":["CHEMBL2107376"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2178573","canonicalSmiles":"Cc1cnc(C(=O)c2ncnc3[nH]ccc23)c(NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)c1","inchiKey":"LUUMLYXKTPBTQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILACIRNON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCX-140","CCX140","CCX140-B","Ccx140","Ilacirnon"],"childChemblIds":["CHEMBL4650229"],"linkedTargets":{"rows":["ENSG00000121807"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","EFO_0004236","MONDO_0005148"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL218006","canonicalSmiles":"C[C@H](NC1=NC(=O)[C@@](C)(C(F)(F)F)S1)c1ccccc1F","inchiKey":"KNHNFKZUNFPPQE-MADCSZMMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL218006","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07310"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2355317","canonicalSmiles":"CCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1","inchiKey":"KXUBAVLIJFTASZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2355317","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206389"],"drugbank":["DB09177"],"chEBI":["61074"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2362016","canonicalSmiles":"O1[As]2O[As]3O[As]1O[As](O2)O3","inchiKey":"KTTMEOWBIWLMSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ARSENIC TRIOXIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trisenox"],"synonyms":["Arseneous anhydride","Arseneous oxide","Arsenic oxide","Arsenic oxide (as4o6)","Arsenic sesquioxide","Arsenic trioxide","Arsenicum album","Arsenous oxide","Diarsenic trioxide","NSC-759274","NSC-92859","Tetraarsenic hexaoxide","White arsenic"],"crossReferences":{"DailyMed":["arsenic%20trioxide"],"PubChem":["144205808"],"chEBI":["30621"]},"linkedTargets":{"rows":["ENSG00000198431"],"count":1},"linkedDiseases":{"rows":["MONDO_0044903","MONDO_0004192","EFO_1001465","MONDO_0007254","MONDO_0020654","EFO_1001951","EFO_0000565","EFO_0002430","EFO_0000339","EFO_0002690","MONDO_0002974","MONDO_0008903","EFO_0000182","MONDO_0001657","EFO_0000330","EFO_0002617","EFO_1000158","EFO_0000479","EFO_0000198","EFO_0000616","MONDO_0013730","EFO_0002618","EFO_0000765","EFO_0000478","EFO_1001512","MONDO_0005341","EFO_0000222","MONDO_0004986","MONDO_0008627","EFO_0000224","EFO_0002429","EFO_0003060","EFO_0000621","MONDO_0008315","EFO_0000311","MONDO_0002691","EFO_0000095","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_0001378"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 35 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL240597","canonicalSmiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","inchiKey":"RUDATBOHQWOJDD-BSWAIDMHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHENODIOL","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chendol 125","Chendol 250","Chenix","Chenocedon","Chenodiol","Chenofalk","Combidol","Lithofalk","Xenbilox"],"synonyms":["Anthropodeoxycholic acid","Anthropodesoxycholic acid","Anthropododesoxycholic acid","Chendol","Chenic acid","Chenocol","Chenodeoxycholate","Chenodeoxycholic acid","Chenodesoxycholic acid","Chenodiol","Chenossil","Cholanorm","Fluibil","Gallodesoxycholic acid","NSC-657949","NSC-757798"],"crossReferences":{"DailyMed":["chenodiol"],"PubChem":["144203963","144207689","26754178","56463362"],"Wikipedia":["Chenodeoxycholic_acid"],"drugbank":["DB06777"],"chEBI":["16755"]},"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["Orphanet_909","EFO_0001074","EFO_0000555","HP_0001258"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL240624","canonicalSmiles":"COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1","inchiKey":"DTYWJKSSUANMHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRELADENANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-3814","Preladenant","SCH 420814","SCH-420814","Sch-420814"],"crossReferences":{"drugbank":["DB11864"]},"childChemblIds":["CHEMBL540115"],"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0005180","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL247484","canonicalSmiles":"O=c1cc(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"ARSRJFRKVXALTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5,7,3',4',5'-Pentahydroxyflavone","Tricetin","Tricetinidin"],"crossReferences":{"PubChem":["26749695"],"drugbank":["DB08230"],"chEBI":["507499"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261454","canonicalSmiles":"c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1","inchiKey":"IBCXZJCWDGCXQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HTS-466284","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HTS-466284","LY-364947"],"crossReferences":{"PubChem":["50112980"],"drugbank":["DB03921"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL269264","canonicalSmiles":"Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21","inchiKey":"UQHKJRCFSLMWIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL269264","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01946"]},"childChemblIds":["CHEMBL3430781"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272114","canonicalSmiles":"Cn1cnc2cc(C#N)c(-c3ccccc3Cl)c(CN)c21","inchiKey":"YJLVMTVZVJSNHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL272114","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273264","canonicalSmiles":"N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1","inchiKey":"MQQNFDZXWVTQEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFAMOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nafamostat"],"crossReferences":{"PubChem":["26754619","29216079","89650190"],"drugbank":["DB12598"]},"childChemblIds":["CHEMBL1091841","CHEMBL3989553"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL276832","canonicalSmiles":"NNc1nncc2ccccc12","inchiKey":"RPTUSVTUFVMDQK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDRALAZINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydralazine","Hydralazine polistirex","NSC-126699"],"crossReferences":{"DailyMed":["hydralazine%20hydrochloride"],"PubChem":["11111261","11111262","174006923","50111090","90341825"],"Wikipedia":["Hydralazine"],"drugbank":["DB01275"],"chEBI":["5775"]},"childChemblIds":["CHEMBL542541"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for hypertension and has 18 investigational indications."}
{"id":"CHEMBL277535","canonicalSmiles":"c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1","inchiKey":"OCAPBUJLXMYKEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFONAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mycospor"],"synonyms":["BAY H 4502","BAY-H-4502","Bifonazole","D01AC10","NSC-758954"],"crossReferences":{"PubChem":["104171382","144204401","170465826","26719682","26747221","56422098","855867"],"Wikipedia":["Bifonazole"],"drugbank":["DB04794"],"chEBI":["78692"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL281398","canonicalSmiles":"CC(C)(C)/N=C(\\NC#N)Nc1cccc(/C(=C\\CCCC(=O)O)c2cccnc2)c1","inchiKey":"XUTLOCQNGLJNSA-RGVLZGJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERBOGREL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIBV 308 SE","BIBV-308-SE","BIBV-308SE","Terbogrel"],"crossReferences":{"Wikipedia":["Terbogrel"],"drugbank":["DB12204"]},"linkedTargets":{"rows":["ENSG00000059377","ENSG00000006638"],"count":2},"linkedDiseases":{"rows":["EFO_0001361"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL286678","canonicalSmiles":"O=Cc1ccccc1OP(=O)(O)O","inchiKey":"BYNSFVCWJXZPOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL286678","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01947"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL287631","canonicalSmiles":"NC(=O)CCC/N=C(\\c1ccc(Cl)cc1)c1cc(F)ccc1O","inchiKey":"IBALRBWGSVJPAP-HEHNFIMWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROGABIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gabren"],"synonyms":["Progabide","SL 76 002","SL-76002"],"crossReferences":{"Wikipedia":["Progabide"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL301265","canonicalSmiles":"CCCN[C@H]1CCc2nc(N)sc2C1","inchiKey":"FASDKYOPVNHBLU-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMIPEXOLE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mirapexin","Neliprax","Oprymea","Pipexus"],"synonyms":["NSC-760426","Pramipexole","SUD-919CL2Y","SUD919CL2Y","U-98528E"],"crossReferences":{"DailyMed":["pramipexole%20dihydrochloride"],"PubChem":["144205998","170465264","50112695"],"Wikipedia":["Pramipexole"],"drugbank":["DB00413"],"chEBI":["8356"]},"childChemblIds":["CHEMBL3143955","CHEMBL542257","CHEMBL3182733"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005203","EFO_0002610","EFO_0005687","HP_0012532","MONDO_0002009","EFO_0001358","EFO_1001412","EFO_0000289","MONDO_0002050","MONDO_0002491","MONDO_0005180","EFO_0004895","MONDO_0004975","EFO_0009854","MONDO_0004976","EFO_0004242","EFO_0004270","EFO_0005411","EFO_0003108"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for parkinson disease and restless legs syndrome and has 16 investigational indications."}
{"id":"CHEMBL3039508","canonicalSmiles":"CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"WCYDLROFMZJJLE-RTMHEQJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALDEMEDINE TOSYLATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2105755","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Symproic"],"synonyms":["Naldemedine tosilate","Naldemedine tosylate"],"crossReferences":{"DailyMed":["naldemedine%20tosylate"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843","HP_0002019","MONDO_0002203"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL327127","canonicalSmiles":"Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21","inchiKey":"ZIQFYVPVJZEOFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0166326","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-0166326","PD-166326"],"crossReferences":{"drugbank":["DB08339"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL341824","canonicalSmiles":"Nc1nc(O)c2nc(CNc3ccc(C(=O)O)cc3)cnc2n1","inchiKey":"JOAQINSXLLMRCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PTEROIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Peroic Acid","Pteroic Acid"],"crossReferences":{"drugbank":["DB04196"],"chEBI":["27623"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545363","canonicalSmiles":"CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O","inchiKey":"MLSQGNCUYAMAHD-ITNVBOSISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLECAPREVIR","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A-1282576","A-1282576.0","A-12825760","ABT-493","Glecaprevir"],"crossReferences":{"DailyMed":["glecaprevir"],"drugbank":["DB13879"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for chronic hepatitis c virus infection and has 4 investigational indications."}
{"id":"CHEMBL3545417","drugType":"Small molecule","blackBoxWarning":false,"name":"GLPG0492","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-GLPG-0492","DT-200","G 100192","GLPG0492","Glpg-0492","Glpg0492"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL363302","canonicalSmiles":"O=C(O)CNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12","inchiKey":"VXTCEUDVOCLEJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL363302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07653"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707244","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@H](COP(=O)(O)O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(=O)O)CSSC[C@H](NC1=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)CSSC[C@H](N)C(=O)N2","inchiKey":"FZQZIDKDPOOFLL-VSMCNCMQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RECANACLOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IW-9179","Recanaclotide"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707356","drugType":"Small molecule","blackBoxWarning":false,"name":"SYL-1001","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SYL-1001","SYL1001","Syl-1001","Tivanisiran"],"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["HP_0200026","EFO_1000906"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3787344","canonicalSmiles":"Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1","inchiKey":"IOMMMLWIABWRKL-WUTDNEBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAZARTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EGF-816","EGF816","Egf816","NVP-EGF816-NX","Nazartinib"],"childChemblIds":["CHEMBL4297222","CHEMBL3984979"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000849","MONDO_0008903","EFO_0003060"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL392990","canonicalSmiles":"c1ccc(-c2oc3nccc(NCCN4CCNCC4)c3c2-c2ccccc2)cc1","inchiKey":"QUIQCYFSBGOBKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL392990","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07146"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL394484","canonicalSmiles":"O=C1CN(c2csc(-c3ccccc3)c2Cl)S(=O)(=O)N1","inchiKey":"LCPRWBWCEGWNKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL394484","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07134"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989844","canonicalSmiles":"C[C@H](N)Cc1ccccc1.O=C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"VHKVKWTWHZUFIA-DGOKBZBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROAMPHETAMINE SACCHARATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL612","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D-amphetamine saccharate","Dexamfetamine hemisaccharate","Dexamfetamine saccharate","Dexamfetaphine saccharate","Dextroamphetamine saccharate"],"crossReferences":{"DailyMed":["dextroamphetamine%20saccharate"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319","ENSG00000165646"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0016158"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for narcolepsy-cataplexy syndrome and attention deficit hyperactivity disorder."}
{"id":"CHEMBL3990025","drugType":"Antibody","blackBoxWarning":false,"name":"OLENDALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALXN-1007","ALXN1007","ALXN1007 antibody","Alxn1007","Lendalizumab","Olendalizumab"],"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["EFO_0002689","EFO_0004599"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL404116","canonicalSmiles":"C/C1=C/C(=O)O[C@@H]2C[C@@H](CC[C@H](C)/C=C\\C=C\\CC1)O[C@@](O)([C@@H]1CSC(=O)N1)C2","inchiKey":"DDVBPZROPPMBLW-IZGXTMSKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATRUNCULIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["486579"],"drugbank":["DB02621"],"chEBI":["69136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406105","canonicalSmiles":"O=C(O)c1cnn(-c2ccccc2)c1","inchiKey":"ZROILLPDIUNLSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406105","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4089731","canonicalSmiles":"Cn1ncc(S(=O)(=O)N2CC[C@H]3Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)n1","inchiKey":"HWJYJKAURRIWJM-GKVSMKOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXICORILANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CORT-125281","CORT125281","Cort125281","Exicorilant"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL412873","canonicalSmiles":"C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1","inchiKey":"SLRCCWJSBJZJBV-TUVASFSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPARTEINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Sparteine"],"childChemblIds":["CHEMBL2303617","CHEMBL1900403","CHEMBL3138647"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiac arrhythmia. It was withdrawn in United States."}
{"id":"CHEMBL4297088","canonicalSmiles":"N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"YZIYKJHYYHPJIB-UUPCJSQJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXIDINE GLUCONATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL790","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Acriflex","Aerocide 1","Bacticlens","Bioscrub","Brian care","Cepton","Cetriclens","Cetriclens fte","Chg scrub","Chloraprep","Chlorhex glucon","Chlorhexidine gluconate","Cida-stat","Clinivex","Corsodyl","Corsodyl daily","Corsodyl daily defence","Curasept","Cx 1","Cyteal","Dispray 1","Dispray 2","Dyna-hex","E-z scrub","Eczmol","Exidine","Gppe soln","Gppe tinct","Gppe wsh","Hibi","Hibicet","Hibiclens","Hibidil","Hibiscrub","Hibispray","Hibistat","Hibitane plus","Hydrex","Microderm","Paroex","Peridex","Perio-kin","Periochip","Periogard","Pharmaseal scrub care","Phiso-med","Prevacare","Prevacare r","Primahex","Readyprep chg","Rotersept","Savloclens","Savlodil","Savlon hc","Savlon jnr","Sterets tisept","Sterets uniscrub","Sterets unisept","Sterexidine","Steri-stat","Tarodent","Tisept","Uriflex-c"],"synonyms":["Chlohexidine gluconate ","Chlorhexidine d-digluconate","Chlorhexidine digluconate","Chlorhexidine gluconate","NSC-753971"],"crossReferences":{"DailyMed":["chlorhexidine%20gluconate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 3 approved and 14 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL4297211","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O.CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O.CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)[O-])cc1.O.O=S(=O)([O-])[O-]","inchiKey":"QNMVZYPDWLKAJC-RXVBEKIDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFIDEROCOL SULFATE TOSYLATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989974","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fetroja"],"synonyms":["Cefiderocol sulfate tosylate","GSK-2696266D","GSK2696266D","S-649266D"],"crossReferences":{"DailyMed":["cefiderocol%20sulfate%20tosylate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for bacterial pneumonia and urinary tract infection."}
{"id":"CHEMBL4297425","canonicalSmiles":"CCCCCCCCCCCCOC(=O)CCCc1nc2cc(N(CCCl)CCCl)ccc2n1C","inchiKey":"RJNURICEBYUKHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDAMUSTINE DODECYL ESTER","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bendamustine dodecyl ester","CEP-40125","RXDX-107","Rxdx-107"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297594","canonicalSmiles":"CC(C)OCCn1c(=S)[nH]c(=O)c2[nH]ccc21","inchiKey":"FVJCUZCRPIMVLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERDIPERSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3241","AZD3241","Azd 3241","Azd3241","BHV-3241","BHV-3421","Verdiperstat"],"crossReferences":{"drugbank":["DB12440"]},"linkedTargets":{"rows":["ENSG00000005381"],"count":1},"linkedDiseases":{"rows":["EFO_1001050","MONDO_0005180","MONDO_0004976","Orphanet_100069"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297615","canonicalSmiles":"CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1","inchiKey":"ZQPDJCIXJHUERQ-QWRGUYRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARSACLISIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-050465","INCB050465","Incb050465","Parsaclisib"],"crossReferences":{"drugbank":["DB14867"]},"childChemblIds":["CHEMBL4298155"],"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","EFO_0000403","MONDO_0007254","EFO_1001264","EFO_1001469","EFO_0000311","EFO_0000211","EFO_0004251","EFO_0000096","EFO_0000095","MONDO_0011962","EFO_0000574","MONDO_0018906","MONDO_0024880","EFO_0000699","EFO_0004719","MONDO_0000430"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL4297639","canonicalSmiles":"CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5cncc(-c6cccc(F)c6)c5[nH]4)c3c2)c1","inchiKey":"AQDWDWAYVBQMAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORECIVIVINT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adavivint","Lorecivivint","SM-04690","SM04690","Sm04690"],"crossReferences":{"drugbank":["DB14883"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297818","drugType":"Enzyme","blackBoxWarning":false,"name":"RELOXALIASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alln-177","Reloxaliase"],"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297934","drugType":"Unknown","blackBoxWarning":false,"name":"DIAPEP-277","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DIAPEP277","Diapep-277","Diapep277"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298125","drugType":"Unknown","blackBoxWarning":false,"name":"ALBUSOMATROPIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albusomatropin","Albutropin","Tv-1106"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL45483","canonicalSmiles":"CNC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)[C@@H](CC(=O)NO)CC(C)C","inchiKey":"QYZPDCGWIJYZMN-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-44463","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-44463"],"crossReferences":{"drugbank":["DB07926"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594352","canonicalSmiles":"CC[C@@]1(OC(=O)C(C)ON=C2c3cc([N+](=O)[O-])cc([N+](=O)[O-])c3-c3c2cc([N+](=O)[O-])cc3[N+](=O)[O-])C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1","inchiKey":"JCCCLGDYMMTBPM-HXDHBHDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TLC-388","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lipotecan","Lipothecan free base","Tlc-388"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000681","EFO_0000182"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL462228","canonicalSmiles":"Clc1ccccc1Nc1ncc(-c2ccccc2)n2cncc12","inchiKey":"NNBICZMPIJMWGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL462228","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08055"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL463580","canonicalSmiles":"O=C(Nc1c[nH]nc1C(=O)Nc1ccc(F)cc1)c1ccccc1","inchiKey":"ZMWYSLJBNJUCRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL463580","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08137"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650299","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"HEPARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B01AB10","Heparin","Heparin, porcine"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650324","canonicalSmiles":"O=C(NCc1cnc(C(F)(F)F)s1)c1ccc2c(c1)NC(=O)c1ccccc1S2(=O)=O","inchiKey":"LBJVBJYMZKEREY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEBICORVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABI-H0731","Abi-h0731","Vebicorvir"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650404","drugType":"Unknown","blackBoxWarning":false,"name":"LEISH-F3","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leish-f3"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650452","drugType":"Unknown","blackBoxWarning":false,"name":"BNC-210","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BNC-210","BNC210","Bnc-210","Bnc210","Iw-2143"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL496879","canonicalSmiles":"N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CC[C@@H](NCc3cncn3C2)C1=O","inchiKey":"USPFJPDEADLGIG-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL496879","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08674"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL496942","canonicalSmiles":"Cn1c(=O)n(Cc2ccc(C(=O)O)cc2)c(=O)c2cc(C#CCc3ccccc3)ccc21","inchiKey":"FLTYDFYSVZBKOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL496942","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07827"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL514270","canonicalSmiles":"COc1ccc(N2CCc3c(-n4ccc(N5CCNC5=O)n4)cc(C)nc32)c(C)c1","inchiKey":"JFHJGXQFESYQGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMICERFONT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emicerfont","GW-876008","GW-876008X","GW876008","GW876008X","Gw876008"],"crossReferences":{"drugbank":["DB12910"]},"linkedTargets":{"rows":["ENSG00000120088"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_1001917"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL519939","canonicalSmiles":"CC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1","inchiKey":"TYPILNNEZPSNTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL519939","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56367","canonicalSmiles":"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1","inchiKey":"HYWYRSMBCFDLJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIMESULIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aulin"],"synonyms":["NSC-758412","Nimesulide","R 805","R-805"],"crossReferences":{"PubChem":["11111520","11111521","124880853","144203758","144212167","170465612","26746940","26751468","50103974","56422364","85231150","855635"],"TG-GATEs":["136"],"Wikipedia":["Nimesulide"],"drugbank":["DB04743"],"chEBI":["44445"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL567597","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4","inchiKey":"BLUAFEHZUWYNDE-DKGJTOOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEMISININ","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artemisin"],"synonyms":["(+)-Artemisinin","Artemisinin","Artemisininum","GNF-PF-5341","Huanghuahaosu","NSC-369397","Qing hau sau"],"crossReferences":{"PubChem":["26755288"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for malaria and has 2 investigational indications."}
{"id":"CHEMBL584","canonicalSmiles":"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C","inchiKey":"QAGYKUNXZHXKMR-HKWSIXNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NELFINAVIR","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-747167","Nelfinavir","Viracept"],"crossReferences":{"DailyMed":["nelfinavir%20mesylate"],"PubChem":["56320472"],"drugbank":["DB00220"],"chEBI":["7496"]},"childChemblIds":["CHEMBL1205"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved and 25 investigational indications."}
{"id":"CHEMBL593019","canonicalSmiles":"Cc1ncc(CO)c(CN)c1O","inchiKey":"NHZMQXZHNVQTQA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyridoxamine","Pyridoxylamine"],"crossReferences":{"PubChem":["4252720"],"Wikipedia":["Pyridoxamine"],"drugbank":["DB11673"],"chEBI":["16410"]},"childChemblIds":["CHEMBL1977058","CHEMBL2361504"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL594","canonicalSmiles":"CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21","inchiKey":"KBUZBQVCBVDWKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMEDASTINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Emadine","Emedastine"],"crossReferences":{"PubChem":["50125935"],"Wikipedia":["Emedastine"],"drugbank":["DB01084"],"chEBI":["4779"]},"childChemblIds":["CHEMBL2103739"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005751"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and is indicated for eye allergy."}
{"id":"CHEMBL599","canonicalSmiles":"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1","inchiKey":"ZRVUJXDFFKFLMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MELOXICAM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anjeso","Meloxicam","Mobic","Qmiiz odt","Vivlodex"],"synonyms":["Acticam","Contacera","Coxicam","Emdocam","Flexicam","Inflacam","Loxicom","Melfax","Melosus","Melovem","Meloxicam","Meloxidolor","Meloxidyl","Meloxivet","Meloxoral","Metacam","Movatec","N-1539","N1539","Recocam","Revitacam","Rheumocam","UH-AC 62XX","UH-AC-62 XX","UHAC-62XX"],"crossReferences":{"DailyMed":["meloxicam"],"PubChem":["144205287","144206743","144208887","144213073","170464857","26747003","50085983","855815"],"TG-GATEs":["124"],"Wikipedia":["Meloxicam"],"drugbank":["DB00814"],"chEBI":["6741"]},"childChemblIds":["CHEMBL1898907","CHEMBL1256873"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["Orphanet_30391","EFO_0000685","EFO_0010072","EFO_0003898","Orphanet_3389","EFO_0003843","EFO_0005755","EFO_0002609","MONDO_0005277","EFO_0002690","HP_0030834","EFO_0000673","HP_0100607","HP_0003419","EFO_0005611","MONDO_0002258","MONDO_0005178"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 4 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL62855","canonicalSmiles":"CN(C/C=C/COc1ccc(C(=O)c2ccc(Br)cc2)cc1)C1CC1","inchiKey":"JAZMZJDLZUDIDG-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62855","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08458"]},"childChemblIds":["CHEMBL479653"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6622","canonicalSmiles":"O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]","inchiKey":"MOYKHGMNXAOIAT-JGWLITMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOSORBIDE DINITRATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angitak","Carvasin","Cedocard","Cedocard ret","Cedocard-10","Cedocard-20","Cedocard-40","Cedocard-5","Dilatrate","Dilatrate-sr","Imtack","Iso mack","Isocard","Isoket 10","Isoket 20","Isoket 5","Isoket ret 20","Isoket ret 40","Isordil","Isordil tembids","Isosorbide dinitrate","Jeridin","Soni-slo","Sorbichew","Sorbid sa","Sorbid-20 sa","Sorbid-40 sa","Sorbidilat","Sorbitrate","Vascardin"],"synonyms":["C01DA08","Diluted isosorbide dinitrate","Diluted isosorbide dinitrate rs","Diluted-isosorbide dinitrate","Isomannide dinitrate","Isomannide-dinitrate","Isosorbide dinitrate","Isosorbide dinitrate, diluted","Isosorbide dinitrate, diluted-","Isosorbidi dinitras dilutes","Isosorbidi dinitras dilutus","NSC-80038","Sorbide nitrate"],"crossReferences":{"DailyMed":["isosorbide%20dinitrate"],"PubChem":["144204870","170464980","57260297"],"drugbank":["DB00883"],"chEBI":["6061"]},"linkedTargets":{"rows":["ENSG00000061918","ENSG00000123201"],"count":2},"linkedDiseases":{"rows":["Orphanet_98896","EFO_1001459","EFO_1001375","EFO_0001645","EFO_0000373","EFO_0009552","EFO_0000319","EFO_1000882","EFO_0005672","EFO_0003913"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 approved and 5 investigational indications."}
{"id":"CHEMBL67279","canonicalSmiles":"CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O","inchiKey":"FKCMADOPPWWGNZ-YUMQZZPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALABOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PT-100","Talabostat","Valinyl-L-Boroproline"],"crossReferences":{"drugbank":["DB06182"]},"childChemblIds":["CHEMBL3545064"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL71595","canonicalSmiles":"OO","inchiKey":"MHAJPDPJQMAIIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROGEN PEROXIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crystacide","Eskata","Hioxyl","Peroxyl"],"synonyms":["A-101","Hydrogen Peroxide","Hydrogen peroxide","Hydrogen peroxide solution","Hyrogen peroxide","NSC-19892","Oxydol"],"crossReferences":{"DailyMed":["hydrogen%20peroxide"],"Wikipedia":["Hydrogen_peroxide"],"drugbank":["DB11091"],"chEBI":["16240"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved and 8 investigational indications."}
{"id":"CHEMBL751","canonicalSmiles":"Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.[Na+]","inchiKey":"HZFGMQJYAFHESD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMFENAC SODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1077","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Saudi Arabia"," United States"],"classes":["Hepatotoxicity"," Misuse"],"year":1998},"tradeNames":["Bromday","Bromfenac sodium","Bromsite","Prolensa","Xibrom"],"synonyms":["AHR-10282B","Bromfenac monosodium salt","Bromfenac monosodium salt sesquihydrate","Bromfenac sodium","Bromfenac sodium anhydrous","Bromfenac sodium hydrate","Bromfenac sodium sesquihydrate"],"crossReferences":{"DailyMed":["bromfenac%20sodium"],"chEBI":["140536"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MP_0001845","HP_0200026","MONDO_0005129","EFO_0009321"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved indications. It was withdrawn in Saudi Arabia and  United States initially in 1998 due to Hepatotoxicity and  Misuse."}
{"id":"CHEMBL79261","canonicalSmiles":"O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cc(Cl)cc3c2OCCO3)CC1","inchiKey":"LYXKFNHUJJDTIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DU 125530","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DU-125530","Du 125530","Du125530"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL836","canonicalSmiles":"CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1","inchiKey":"DRHKJLXJIQTDTD-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAMSULOSIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["HGP-0412","HIP-1402","HIP1402","Tamsulon","Tamsulosin"],"crossReferences":{"DailyMed":["tamsulosin%20hydrochloride"],"Wikipedia":["Tamsulosin"],"drugbank":["DB00706"],"chEBI":["9398"]},"childChemblIds":["CHEMBL1200914"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["MONDO_0024647","HP_0000016","HP_0006000","EFO_0005323","EFO_0004234","EFO_0000284","EFO_0000536","MONDO_0008315","EFO_0001663","EFO_0000537","HP_0011277","MONDO_0001187","EFO_1001412","EFO_0004253","HP_0000020","EFO_1001228","EFO_1000781","EFO_0003830","EFO_0009321","HP_0000011"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for prostate carcinoma and benign prostatic hyperplasia and has 11 investigational indications."}
{"id":"CHEMBL965","canonicalSmiles":"C[N+](C)(C)CCOC(N)=O","inchiKey":"VPJXQGSRWJZDOB-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBACHOL","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbachol","Carbastat","Miostat"],"crossReferences":{"DailyMed":["carbachol"],"PubChem":["11110943","11110944","26756576","90341139"],"drugbank":["DB00411"]},"childChemblIds":["CHEMBL14"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["MONDO_0001330","MONDO_0005129","EFO_0000516","HP_0000616"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 3 approved and 1 investigational indication."}
